Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Autoimmunity ; 42(3): 183-97, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19301199

RESUMO

The MerTK receptor tyrosine kinase is an important negative regulator of dendritic cell function and is required to prevent B cell autoimmunity in vivo. It is not currently known however, if any causal relationship exists between these two aspects of MerTK function. We sought to determine if dendritic cells (DC) from mice lacking MerTK (mertk(- / - ) mice) have characteristics that may aid in the development of B cell autoimmunity. Specifically, we found that mertk(- / - ) mice contain an elevated number of splenic DC, and this population contains an elevated proportion of cells secreting the critical B cell pro-survival factor, B cell activating factor (BAFF). Elevated numbers of BAFF-secreting cells were also detected among mertk(- / - ) bone marrow-derived dendritic cell (BMDC) populations. This was observed in both resting BMDC, and BMDC stimulated with lipopolysaccharide (LPS) or treated with exogenous apoptotic cells. We also found that DC in general have a pro-survival effect on resting B cells in co-culture. However, despite containing more BAFF-secreting cells, mertk(- / - ) BMDC were not superior to C57BL/6 or baff-deficient BMDC at promoting B cell survival. Furthermore, using decoy receptors, we show that DC may promote B cell survival and autoimmunity through a BAFF-and a proliferation-inducing ligand-independent mechanism.


Assuntos
Fator Ativador de Células B/metabolismo , Células Dendríticas/metabolismo , Proteínas Proto-Oncogênicas/fisiologia , Receptores Proteína Tirosina Quinases/fisiologia , Fatores Etários , Animais , Anticorpos Antinucleares/sangue , Anticorpos Antinucleares/imunologia , Autoimunidade/fisiologia , Fator Ativador de Células B/sangue , Fator Ativador de Células B/farmacologia , Linfócitos B/citologia , Linfócitos B/fisiologia , Células da Medula Óssea/citologia , Células da Medula Óssea/efeitos dos fármacos , Contagem de Células , Diferenciação Celular/efeitos dos fármacos , Sobrevivência Celular/fisiologia , Cromatina/imunologia , Técnicas de Cocultura , DNA/imunologia , Células Dendríticas/citologia , Células Dendríticas/efeitos dos fármacos , Células Dendríticas Foliculares/citologia , Células Dendríticas Foliculares/metabolismo , Expressão Gênica/genética , Interferon gama/farmacologia , Lipopolissacarídeos/farmacologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Proteínas Recombinantes/farmacologia , Baço/citologia , Baço/metabolismo , Membro 13 da Superfamília de Ligantes de Fatores de Necrose Tumoral/fisiologia , c-Mer Tirosina Quinase
2.
Immunity ; 10(2): 239-48, 1999 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10072076

RESUMO

B cell antigen receptor (BCR) ligation leads to receptor desensitization wherein BCR remain competent to bind antigen and yet fail to transduce signals. Desensitized BCR exhibit a defect at the most proximal level of signal transduction, consistent with failed transmission of signals through the receptor complex. We report that antigen stimulation leads to dissociation or destabilization of the BCR reflected by inability to coimmunoprecipitate Ig-alpha/Ig-beta with mIg. This destabilization is temporally correlated with desensitization and occurs in BCR containing mIgM and mIgD. Induction of BCR destabilization requires tyrosine kinase activation but is not induced by phosphatase inhibitors. BCR destabilization occurs at the cell surface and "dissociated" Ig-alpha/Ig-beta complexes remain responsive to anti-Ig-beta stimulation, suggesting that mIg-transducer uncoupling may mediate receptor desensitization.


Assuntos
Antígenos CD/imunologia , Receptores de Antígenos de Linfócitos B/imunologia , Antígenos CD79 , Ativação Enzimática , Precursores Enzimáticos/metabolismo , Humanos , Imunoglobulina D/metabolismo , Imunoglobulina M/metabolismo , Peptídeos e Proteínas de Sinalização Intracelular , Substâncias Macromoleculares , Ligação Proteica , Proteínas Tirosina Quinases/metabolismo , Transdução de Sinais , Quinase Syk , Células Tumorais Cultivadas , Quinases da Família src/metabolismo
3.
J Immunol ; 159(1): 231-43, 1997 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-9200459

RESUMO

Antigen binding to the B cell receptor (BCR) induces receptor desensitization, a condition characterized by cellular unresponsiveness to subsequent Ag stimulation despite the continued ability to bind Ag. To better understand the molecular mechanism of this unresponsiveness, we have used complementary lymphoma (K46 mu) and Ig transgenic (3-83 mu delta) mouse models to study regulation of BCR signaling. Our findings in the lymphoma model show that an initial Ag encounter renders receptors unresponsive to subsequent Ag challenge, as measured by their inability to mobilize Ca2+ and to mediate phosphorylation of receptor-proximal kinases, including Lyn, Blk, and Syk. Most importantly, the Ig alpha and Ig beta components of desensitized receptors are not phosphorylated, and receptor-associated kinases are not activated upon Ag challenge. The molecular defect does not appear to result from Lyn inactivation, sequestration, or repression, since Lyn from desensitized cell lysates is activated in vitro by synthetic doubly phosphorylated immunoreceptor tyrosine-based activation motif peptides. A similar deficit in Ag-induced receptor phosphorylation was observed in desensitized B cells from 3-83 mu delta transgenic mice. These studies indicate that Ag receptor desensitization reflects an inability to initiate activation of receptor-associated kinases that normally phosphorylate receptor Ig alphabeta subunits, leading to signal propagation.


Assuntos
Linfócitos B/imunologia , Proteínas Tirosina Quinases/metabolismo , Receptores de Antígenos de Linfócitos B/metabolismo , Transdução de Sinais/imunologia , Animais , Antígenos/imunologia , Linfócitos B/metabolismo , Humanos , Ligantes , Linfoma , Camundongos , Camundongos Transgênicos , Proteínas Tirosina Quinases/imunologia , Receptores de Antígenos de Linfócitos B/imunologia , Células Tumorais Cultivadas
4.
J Biol Chem ; 270(36): 20978-86, 1995 Sep 08.
Artigo em Inglês | MEDLINE | ID: mdl-7673122

RESUMO

Expression of the major histocompatibility complex (MHC) class II-associated invariant chain (Ii) is required for efficient and complete presentation of antigens by MHC class II molecules and a normal immune response. The Ii gene is generally co-regulated with the MHC class II molecules at the level of transcription and a shared SXY promoter element has been described. This report defines the proximal promoter region of Ii which may regulate Ii transcription distinct from MHC class II. In vivo genomic footprinting identified an occupied, imperfect CCAAT box and an adjacent GC box in the proximal region. These sites are bound in Ii-ositive cell lines and upon interferon-gamma induction of Ii transcription. In contrast, both sites are unoccupied in Ii-egative cell lines and in inducible cell lines prior to interferon-gamma treatment. Together these two sites synergize to stimulate transcription. Independently, the transcription factor NF-Y binds poorly to the imperfect CCAAT box with a rapid off rate, while Sp1 binds to the GC box. Stabilization of NF-Y binding occurs upon Sp1 binding to DNA. In addition, the half-life of Sp1 binding also increased in the presence of NF-Y binding. These findings suggest a mechanism for the complete functional synergy of the GC and CCAAT elements observed in Ii transcription. Furthermore, this report defines a CCAAT box of imperfect sequence which binds NF-Y and activates transcription only when stabilized by an adjacent factor, Sp1.


Assuntos
Antígenos de Diferenciação de Linfócitos B/genética , Proteínas de Ligação a DNA/metabolismo , Regulação da Expressão Gênica , Antígenos de Histocompatibilidade Classe II/genética , Fator de Transcrição Sp1/metabolismo , Animais , Sequência de Bases , Proteínas Estimuladoras de Ligação a CCAAT , DNA , Meia-Vida , Humanos , Dados de Sequência Molecular , Regiões Promotoras Genéticas , Ligação Proteica , Transcrição Gênica , Células Tumorais Cultivadas , Regulação para Cima
5.
EMBO J ; 13(17): 4042-53, 1994 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-8076600

RESUMO

NF-Y binds a CCAAT motif found in many eukaryotic polymerase II-dependent promoters. In the HLA-DRA promoter it has been demonstrated that stereo-specific alignment between this motif and the upstream elements X1 and X2 is required for activation. To study the underlying mechanism for this requirement, a panel of transfected cell lines that maintained integrated, wild-type and mutant promoters were analyzed by in vivo genomic footprinting. Cell lines harboring a mutated CCAAT element exhibited a loss of interactions at the CCAAT site, as expected, and no transcriptional activity. Most importantly, mutation of the CCAAT sequence nearly abolished in vivo binding at the X1 and X2 sites, while mutations of X1 and X2 had little effect on CCAAT box binding. However, X1 and X2 binding was interdependent. In vitro, X1 binding activities are known to be stabilized by NF-Y binding. Interaction between NF-Y and X box binding proteins was demonstrated by reciprocal co-immunoprecipitation in the absence of DNA and co-affinity purification in the presence of DNA. Collectively, these studies indicate that occupancy of the CCAAT element represents an early event affecting other protein-DNA interactions and suggest that NF-Y stabilizes and interacts with X box factors to mediate this function. These findings may represent a common theme among promoters containing a CCAAT element.


Assuntos
Antiporters , Proteínas de Transporte , Proteínas de Ligação a DNA/metabolismo , Antígenos de Histocompatibilidade Classe II/genética , Proteínas de Membrana , Regiões Promotoras Genéticas/genética , Fatores de Transcrição/metabolismo , Transcrição Gênica , Sequência de Bases , Proteínas Estimuladoras de Ligação a CCAAT , Antiportadores de Cloreto-Bicarbonato , Cromatografia de Afinidade , Genes Reporter , Antígenos de Histocompatibilidade Classe II/biossíntese , Humanos , Substâncias Macromoleculares , Modelos Genéticos , Dados de Sequência Molecular , Testes de Precipitina , Ligação Proteica , Proteínas/genética , Transportadores de Sulfato , Transfecção , Células Tumorais Cultivadas
6.
J Biol Chem ; 267(33): 23728-34, 1992 Nov 25.
Artigo em Inglês | MEDLINE | ID: mdl-1331098

RESUMO

Constitutive and inducible transcription of the major histocompatibility class II HLA-DRA gene involves the upstream S element and the conserved X and Y elements. In this report we have addressed the roles of spatial constraints and stereospecific alignment between the upstream S and X elements, and the X and Y elements, in both constitutive and interferon-gamma (gamma-IFN)-induced expression. Analysis of the constitutive expression in B cell lines (B-LCL) has previously shown that the X and Y elements must be stereoaligned. Further study reveals that any spacing changes between S and X, regardless of the helical alignment of these two elements, is not tolerated. These same restraints are involved in an inducible system, because the response to gamma-IFN treatment requires both stereo alignment between the X and Y elements and precise spacing between the S and X elements. Neither constitutive nor inducible expression can be restored by correcting the distance and spacing between only the S and Y elements with misalignment of X. These results reveal a common pathway for constitutive and inducible expression that may require either direct or indirect protein complex formation among proteins bound to three highly conserved regulatory elements. We have also evaluated the role of the A/T-rich sequence located immediately 5' of the Y element and show that it exerts little effect on constitutive and gamma-IFN induced DRA expression.


Assuntos
Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Antígenos HLA-DR/genética , Interferon gama/farmacologia , Regiões Promotoras Genéticas , Sequências Reguladoras de Ácido Nucleico , Transcrição Gênica , Sequência de Bases , Linfoma de Burkitt , DNA Ribossômico/genética , Herpesvirus Humano 4/genética , Humanos , Substâncias Macromoleculares , Dados de Sequência Molecular , Plasmídeos , Proteínas Recombinantes , Transfecção
7.
Mol Cell Biol ; 11(5): 2406-15, 1991 May.
Artigo em Inglês | MEDLINE | ID: mdl-1901941

RESUMO

The regulatory mechanisms controlling expression of the major histocompatibility complex (MHC) class II genes involve several cis-acting DNA elements, including the X and Y boxes. These two elements are conserved within all murine and human class II genes and are required for accurate and efficient transcription from MHC class II promoters. Interestingly, the distance between the X and Y elements is also evolutionarily conserved at 18 to 20 bp. To investigate the function of the invariant spacing in the human MHC class II gene, HLA-DRA, we constructed a series of spacing mutants which alters the distance between the X and Y elements by integral and half-integral turns of the DNA helix. Transient transfection of the spacing constructs into Raji cells revealed that inserting integral turns of the DNA helix (+20 and +10 bp) did not reduce promoter activity, while inserting or deleting half-integral turns of the DNA helix (+15, +5, and -5 bp) drastically reduced promoter activity. The loss of promoter function in these half-integral turn constructs was due neither to the inability of the X and Y elements to bind proteins nor to improper binding of the X- and Y-box-binding proteins. These data indicate that the X and Y elements must be aligned on the same side of the DNA helix to ensure normal function. This requirement for stereospecific alignment strongly suggests that the X- and Y-box-binding proteins either interact directly or are components of a larger transcription complex which assembles on one face of the DNA double helix.


Assuntos
Genes MHC da Classe II , Regiões Promotoras Genéticas , Animais , Sequência de Bases , Linhagem Celular , Núcleo Celular/metabolismo , Cloranfenicol O-Acetiltransferase/genética , Cloranfenicol O-Acetiltransferase/metabolismo , Deleção Cromossômica , DNA de Neoplasias/genética , Humanos , Metilação , Camundongos , Modelos Estruturais , Dados de Sequência Molecular , Conformação de Ácido Nucleico , Plasmídeos , Proteínas Recombinantes de Fusão/metabolismo , Estereoisomerismo , Transfecção
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...